Expressions of markers such as CD40, α5 integrin, CD80, CD86, and HLA-DR are downregulated in monocyte-derived DCs after co-incubation with renal cancer derived-EVs carrying HLA-G, which can be inhibited by anti-HLA-G-antibody. This evidence concerns the gene HLA-G and renal carcinoma.